
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Introduction
Author(s)Gary V. Doern, PhD
Advertisement
Articles in this issue
about 27 years ago
Optimizing Antimicrobial Therapy and Emerging Pathogensabout 27 years ago
Participating Facultyabout 27 years ago
Mechanisms and Current Rates of Resistanceabout 27 years ago
Influence of Antibiotics on the Normal Floraabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: Pediatric Issuesabout 27 years ago
Pharmacoeconomic Impact of Appropriate Clinical Pathwaysabout 27 years ago
CME QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
2
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
3
Experts, Patients Highlight Barriers to Arthritis Care Amid World Arthritis Day Observance
4
Efficacy and Safety of Dupilumab in AD Across Diverse Pediatric Populations: A Q&A With Elaine Siegfried, MD
5